Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Félix Calderón

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
The Journal of Organic Chemistry|July 29, 2006
Synthesis of azasugars through a proline-catalyzed reactionFélix Calderón, Elisa G Doyagüez, Alfonso Fernandez-Mayoralas
The Journal of Organic Chemistry|October 26, 2007
Asymmetric aldol reaction catalyzed by a heterogenized proline on a mesoporous support. The role of the nature of solventsElisa G Doyagüez, Félix Calderón, Félix Sanchez, et al.
Microbiology Spectrum|December 19, 2022
Tyrosine Kinase Inhibitors Display Potent Activity against Cryptosporidium parvumMaria G Nava, Félix Calderón, Elena Fernández, et al.
Journal of Medicinal Chemistry|January 22, 2016
Antimalarial Chemotherapy: Natural Product Inspired Development of Preclinical and Clinical Candidates with Diverse Mechanisms of ActionElena Fernández-Álvaro, W David Hong, Gemma L Nixon, et al.
European Journal of Medicinal Chemistry|December 18, 2007
CODES, a novel procedure for ligand-based virtual screening: PDE7 inhibitors as an application exampleAna Castro, María José Jerez, Carmen Gil, et al.
The Journal of Organic Chemistry|September 25, 2008
Origins of the double asymmetric induction on proline-catalyzed aldol reactionsFélix Calderón, Elisa G Doyagüez, Paul Ha-Yeon Cheong, et al.
ACS Infectious Diseases|January 11, 2018
Efforts Aimed To Reduce Attrition in Antimalarial Drug Discovery: A Systematic Evaluation of the Current Antimalarial Targets PortfolioMaría Jesús Chaparro, Félix Calderón, Pablo Castañeda, et al.
ACS Infectious Diseases|October 31, 2023
Bromodomain Factor 5 as a Target for Antileishmanial Drug DiscoveryCatherine N Russell, Jennifer L Carter, Juliet M Borgia, et al.
ACS Infectious Diseases|October 6, 2021
Expanding Bromodomain Targeting into Neglected Parasitic DiseasesCynthia Tallant, Paul Bamborough, Chun-Wa Chung, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
A Divergent SAR Study Allows Optimization of a Potent 5-HT2c Inhibitor to a Promising Antimalarial ScaffoldFélix Calderón, Jaume Vidal-Mas, Jeremy Burrows, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
The Journal of Organic Chemistry|July 29, 2006
Synthesis of azasugars through a proline-catalyzed reactionFélix Calderón, Elisa G Doyagüez, Alfonso Fernandez-Mayoralas
The Journal of Organic Chemistry|October 26, 2007
Asymmetric aldol reaction catalyzed by a heterogenized proline on a mesoporous support. The role of the nature of solventsElisa G Doyagüez, Félix Calderón, Félix Sanchez, et al.
Microbiology Spectrum|December 19, 2022
Tyrosine Kinase Inhibitors Display Potent Activity against Cryptosporidium parvumMaria G Nava, Félix Calderón, Elena Fernández, et al.
Journal of Medicinal Chemistry|January 22, 2016
Antimalarial Chemotherapy: Natural Product Inspired Development of Preclinical and Clinical Candidates with Diverse Mechanisms of ActionElena Fernández-Álvaro, W David Hong, Gemma L Nixon, et al.
European Journal of Medicinal Chemistry|December 18, 2007
CODES, a novel procedure for ligand-based virtual screening: PDE7 inhibitors as an application exampleAna Castro, María José Jerez, Carmen Gil, et al.
The Journal of Organic Chemistry|September 25, 2008
Origins of the double asymmetric induction on proline-catalyzed aldol reactionsFélix Calderón, Elisa G Doyagüez, Paul Ha-Yeon Cheong, et al.
ACS Infectious Diseases|January 11, 2018
Efforts Aimed To Reduce Attrition in Antimalarial Drug Discovery: A Systematic Evaluation of the Current Antimalarial Targets PortfolioMaría Jesús Chaparro, Félix Calderón, Pablo Castañeda, et al.
ACS Infectious Diseases|October 31, 2023
Bromodomain Factor 5 as a Target for Antileishmanial Drug DiscoveryCatherine N Russell, Jennifer L Carter, Juliet M Borgia, et al.
ACS Infectious Diseases|October 6, 2021
Expanding Bromodomain Targeting into Neglected Parasitic DiseasesCynthia Tallant, Paul Bamborough, Chun-Wa Chung, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
A Divergent SAR Study Allows Optimization of a Potent 5-HT2c Inhibitor to a Promising Antimalarial ScaffoldFélix Calderón, Jaume Vidal-Mas, Jeremy Burrows, et al.
Pageof 3